|Product Name:||Naquotinib mesylate|
|Solubility:||DMSO 12.5 mg/mL|
|Storage:||2-8°C, dry, sealed|
|HPLC:||Shows Min >99% purity|
|H-NMR:||Consistent with structure|
|Description:||Naquotinib mesylate (ASP8273 mesylate) is an orally available, mutant-selective and irreversible EGFR inhibitor; with IC50s of 8-33 nM toward EGFR mutants and 230 nM for EGFR.|
|Stability and Solubility Advice:|| Information concerning product stability, particularly in solution, has rarely been reported and in most cases we can only offer a general guide.
We recommend that stock solutions, once prepared, are stored aliquoted in tightly sealed vials and used within 1 month. Avoid repeated freeze and thaw cycles. Storage conditions for some special products should refer to their storage details.